Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSFOMYCIN TROMETHAMINE vs FOSPHENYTOIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSFOMYCIN TROMETHAMINE vs FOSPHENYTOIN: Safety Overview

Metric FOSFOMYCIN TROMETHAMINE FOSPHENYTOIN
Total FAERS Reports 778 1,378
Deaths Reported 24 166
Death Rate 3.1% 12.0%
Hospitalizations 280 646
Average Patient Age 59.2 yrs 37.5 yrs
% Female Patients 83.9% 52.4%
FDA Approval Date Dec 19, 1996 Aug 5, 1996
Manufacturer Cipla USA Inc. Pfizer Laboratories Div Pfizer Inc
Route ORAL INTRAMUSCULAR
Marketing Status Discontinued Prescription